Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

225.50
Delayed Data
As of 4:00pm ET
 -12.45 / -5.23%
Today’s Change
163.68
Today|||52-Week Range
249.85
+2.99%
Year-to-Date

Stock Price Forecast

The 23 analysts offering 12-month price forecasts for Vertex Pharmaceuticals Inc have a median target of 270.00, with a high estimate of 300.00 and a low estimate of 224.00. The median estimate represents a +19.73% increase from the last price of 225.50.

Analyst Recommendations

The current consensus among 27 polled investment analysts is to Buy stock in Vertex Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$1.78
Sales
$1.3B
Reporting Date
Apr 23

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 4.94%
 
 
 
 
 
 
Growthannually 44.69%
 
 
 
 
 
 

Sales

Growthquarterly 0.27%
 
 
 
 
 
 
Growthannually 32.71%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.